Last reviewed · How we verify

F#13418-158 Eye Drops — Competitive Intelligence Brief

F#13418-158 Eye Drops (F#13418-158 Eye Drops) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Ophthalmology.

phase 3 Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

F#13418-158 Eye Drops (F#13418-158 Eye Drops) — Johnson & Johnson Consumer Inc. (J&JCI). F#13418-158 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
F#13418-158 Eye Drops TARGET F#13418-158 Eye Drops Johnson & Johnson Consumer Inc. (J&JCI) phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). F#13418-158 Eye Drops — Competitive Intelligence Brief. https://druglandscape.com/ci/f-13418-158-eye-drops. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: